Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 1
2012 2
2013 1
2014 1
2015 1
2016 1
2017 1
2018 2
2020 1
2021 1
2022 2
2023 4
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Allodynia in cluster headache.
Wilbrink LA, Louter MA, Teernstra OPM, van Zwet EW, Huygen FJPM, Haan J, Ferrari MD, Terwindt GM. Wilbrink LA, et al. Among authors: teernstra opm. Pain. 2017 Jun;158(6):1113-1117. doi: 10.1097/j.pain.0000000000000891. Pain. 2017. PMID: 28267062
A prospective open label 2-8 year extension of the randomised controlled ICON trial on the long-term efficacy and safety of occipital nerve stimulation in medically intractable chronic cluster headache.
Brandt RB, Wilbrink LA, de Coo IF, Haan J, Mulleners WM, Huygen FJPM, van Zwet EW, Ferrari MD, Fronczek R; ICON study group. Brandt RB, et al. EBioMedicine. 2023 Dec;98:104895. doi: 10.1016/j.ebiom.2023.104895. Epub 2023 Nov 25. EBioMedicine. 2023. PMID: 38007947 Free PMC article. Clinical Trial.
EGFRvIII expression triggers a metabolic dependency and therapeutic vulnerability sensitive to autophagy inhibition.
Jutten B, Keulers TG, Peeters HJM, Schaaf MBE, Savelkouls KGM, Compter I, Clarijs R, Schijns OEMG, Ackermans L, Teernstra OPM, Zonneveld MI, Colaris RME, Dubois L, Vooijs MA, Bussink J, Sotelo J, Theys J, Lammering G, Rouschop KMA. Jutten B, et al. Among authors: teernstra opm. Autophagy. 2018;14(2):283-295. doi: 10.1080/15548627.2017.1409926. Epub 2018 Jan 29. Autophagy. 2018. PMID: 29377763 Free PMC article.
Spinal Cord Stimulation With Additional Peripheral Nerve/Field Stimulation Versus Spinal Cord Stimulation Alone on Back Pain and Quality of Life in Patients With Persistent Spinal Pain Syndrome.
van Heteren EPZ, van Roosendaal BWP, van Gorp EJAA, Bronkhorst EM, Kallewaard JW, Wegener JT, Bürger K, Teernstra OPM, Buschman HPJ, Hamm-Faber TE, Vissers KCP. van Heteren EPZ, et al. Among authors: teernstra opm. Neuromodulation. 2023 Apr;26(3):658-665. doi: 10.1016/j.neurom.2021.11.010. Epub 2022 Jan 26. Neuromodulation. 2023. PMID: 35088732 Clinical Trial.
Subcutaneous Stimulation as Add-on Therapy to Spinal Cord Stimulation in Patients With Persistent Spinal Pain Syndrome Significantly Increases the Total Electrical Charge per Second: Aspects on Stimulation Parameters and Energy Requirements of the Implanted Neurostimulators.
van Roosendaal BWP, van Heteren EPZ, van Gorp EJ, Bronkhorst EM, Kallewaard JW, Wegener JT, Burger K, Teernstra OPM, Buschman HPJ, Hamm-Faber T, Vissers KCP. van Roosendaal BWP, et al. Among authors: teernstra opm. Neuromodulation. 2023 Apr;26(3):666-675. doi: 10.1016/j.neurom.2021.12.005. Epub 2022 Mar 10. Neuromodulation. 2023. PMID: 35279384 Free article. Clinical Trial.
Clinical predictors of pseudoprogression in glioblastoma: a retrospective cohort analysis.
Hoosemans LJN, Panayotopoulos LF, van Kuijk SMJ, Verduin M, Anten MHME, Pasmans RCOS, Schellekens JM, Huijs SMH, Verhoeff SR, van den Berkmortel FWPJ, Steggink LC, Ackermans L, Schijns OEMG, Teernstra OPM, Hovinga K, Beckervordersandforth JC, Compter I, Eekers DBP, Postma AA, Vooijs MA, Broen MPG, Hoeben A. Hoosemans LJN, et al. Among authors: teernstra opm. J Neurooncol. 2025 Oct 24;176(1):42. doi: 10.1007/s11060-025-05299-0. J Neurooncol. 2025. PMID: 41134378 Free PMC article.
Safety and efficacy of occipital nerve stimulation for attack prevention in medically intractable chronic cluster headache (ICON): a randomised, double-blind, multicentre, phase 3, electrical dose-controlled trial.
Wilbrink LA, de Coo IF, Doesborg PGG, Mulleners WM, Teernstra OPM, Bartels EC, Burger K, Wille F, van Dongen RTM, Kurt E, Spincemaille GH, Haan J, van Zwet EW, Huygen FJPM, Ferrari MD; ICON study group. Wilbrink LA, et al. Among authors: teernstra opm. Lancet Neurol. 2021 Jul;20(7):515-525. doi: 10.1016/S1474-4422(21)00101-0. Lancet Neurol. 2021. PMID: 34146510 Clinical Trial.
19 results